eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05689385
Collaborator
(none)
150
2
22

Study Details

Study Description

Brief Summary

The goal of this randomized controlled trial is to compare the effect of eHealth-based cardiac rehabilitation with the effect of usual care on exercise capacity and qualify of life in patients after myocardial infarction.

Condition or Disease Intervention/Treatment Phase
  • Other: eHealth-based cardiac rehabilitation
N/A

Detailed Description

Cardiac rehabilitation can improve exercise capacity, life of quality, readmission rate and mortality rate for patients after myocardial infarction. International guidelines list cardiac rehabilitation after myocardial infarction as class IA recommendation. However, low participation rate of cardiac rehabilitation due to barriers such as lacking of time, transport or affordability issues is an unsolved problem worldwide.

eHealth, consisting of telemedicine, mobile health and personalized care using wearable devices has the potential to remove the barriers and become an effective model to deliver cardiac rehabilitation. Thus, we design a randomized controlled trial to compare the effect of a case manager-led eHealth-based cardiac rehabilitation program with usual care on the compliance, physical activity, quality of life, and cardiorespiratory fitness in patients after myocardial infarction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effectiveness of eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients:a Randomized Controlled Trial.
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: eHealth-based cardiac rehabilitation

Participants receive a 12-wk case manager-led eHealth-based cardiac rehabilitation program with follow-up at 12 week, 6 months and 12 months.

Other: eHealth-based cardiac rehabilitation
The 12-wk case manager-led eHCR program includes: Individualized exercise prescription according to the results of cardiopulmonary exercise test. At least one session of in-person physical therapy to familiarize participants with the process of exercise training before the initiation of telerehabilitation. Telerehabilitation: a 30-minute moderate aerobic exercise training with remote monitoring and instruction using video conferencing. (Frequency: twice per week in the first 4 weeks, once per week in the 5th-8th week, once every 2 weeks in the 9th-12th week) Additional self-exercise to achieve the target volume of 150-minute moderate aerobic exercise and 2 sessions of resistance training per week. Patient education for secondary prevention delivered regularly via a communication app on the smartphone. Weekly follow-up call from a case manager via phone call or communication app.
Other Names:
  • eHCR
  • No Intervention: Usual care

    Participants receive usual care.

    Outcome Measures

    Primary Outcome Measures

    1. Change of peak oxygen uptake [at baseline, 12 weeks(post-intervention), and 12 months.]

      Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.

    2. Change of ventilatory anaerobic threshold [at baseline, 12 weeks(post-intervention), and 12 months.]

      Ventilatory anaerobic threshold will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.

    Secondary Outcome Measures

    1. Adherence to prescribed exercise [at 12 weeks(post-intervention) and 12 months.]

      The degree of completion of prescribed exercise will be assessed at 12 weeks and 12 months.

    2. Evaluation of Quality of life [at baseline, 12 weeks(post-intervention), and 12 months.]

      The investigators will assess the change in 36-Item Short Form Survey(SF-36).

    3. Depression [at baseline, 12 weeks(post-intervention), and 12 months.]

      The investigators will assess the change in Patient Health Questionnaire (PHQ-9). The PHQ-9 score ranges from 0-27. Higher scores indicate worsen symptoms.

    4. Anxiety [at baseline, 12 weeks(post-intervention), and 12 months.]

      The investigators will assess the change in Generalized Anxiety Disorder scale (GAD-7). The GAD-7 score ranges 0-21. Higher scores indicate worsen symptoms.

    5. Evaluation of physical activity [at baseline, 12 weeks(post-intervention), and 12 months.]

      The investigators will assess the change in physical activity using Long form International Physical Activity Questionnaire(IPAQ) Taiwan version.

    6. Evaluation of grip strength [at baseline, 12 weeks(post-intervention), and 12 months.]

      The grip strength will be measured using a grip goniometer with the participants seated and the elbow flexed at 90 degrees.

    7. Evaluation of isometric knee extension strength [at baseline, 12 weeks(post-intervention), and 12 months.]

      The isometric knee extension strength will be measured using a dynamometer with participants seated and knee flexed at 90 degrees.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    1. ≥ 20 years of age.

    2. Within 6 months after the onset of acute myocardial infarction.

    3. At lowest to moderate risk according to the guideline from American Association of Cardiovascular and Pulmonary Rehabilitation.

    4. Unable or refused to attend center-based cardiac rehabilitation.

    Exclusion criteria:
    1. Unable to walk independently or use a stationary bike.

    2. Unable to follow verbal command.

    3. Not having a smartphone which can get on the internet.

    4. Having contraindications for exercise according to American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.

    5. Unable to provide informed consent.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • National Taiwan University Hospital

    Investigators

    • Principal Investigator: Hung-Jui Chuang, MD, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Taiwan University Hospital
    ClinicalTrials.gov Identifier:
    NCT05689385
    Other Study ID Numbers:
    • 202207060RINC
    First Posted:
    Jan 19, 2023
    Last Update Posted:
    Jan 19, 2023
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by National Taiwan University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 19, 2023